Serotyping of quinolone-resistant
conferring fluoroquinolone resistance on N . gonorrhoeae strains, while the change of the ParC subunit of topoisomerase IV has a complementary role. 4 Serotypic characterization studies have demonstrated that the majority of the strains with decreased susceptibilities to fluoroquinolones isolated from different regions around the world are distributed in various serotypes in serogroup WII/III. 1-3 H owever, there have been no studies reporting the relationship between serological classification and alterations in G yrA and ParC proteins in quinolone-resistant isolates of N . gonorrhoeae. In this study, we serotyped 31 isolates with quinolone-resistanceassociated alterations in G yrA and ParC proteins to assess whether alterations in these proteins were associated with one or various clones in the gonococcal population.
The 31 clinical strains of N . gonorrhoeae were isolated between 1991 and 1993 from Japanese patients with gonococcal urethritis. The infections were acquired in Japan, but the isolates were not epidemiologically related. In a previous study, 4 these isolates were examined for the presence of mutations in the quinolone-resistancedetermining region of the gyrA gene and the analogous region of the p a r C gene and tested for their susceptibilities to selected quinolones including ciprofloxacin. In this study, we determined serotypes by a co-agglutination method using a panel of 14 monoclonal antibodies to protein I (Boule D iagnostics A B, H uddinge, Sweden). 5 The Table summarizes In Cleveland, O H , U SA , where none of the public clinics for sexually transmitted diseases have used quinolones in the primary treatment of gonorrhoea, molecular typing using pulsed-field electrophoresis has suggested that a single strain or closely related strains of N . gonorrhoeae accounted for the decreased susceptibility to ciprofloxacin; 6 this has also been suggested by auxotype-serotype analysis.
1 In contrast, a wide variety of phenotypes of N . gonorrhoeae clinical isolates with decreased susceptibilities to fluoroquinolones has been reported in H ong Kong 2 and A ustralia. 3 In this study in Japan, we also found various subtypes of N . gonorrhoeae harbouring quinolone-resistance-associated alterations in G yrA and ParC. Fluoroquinolones have often been used in the primary treatment of gonorrhoea in Japan. This could have a significant influence on the clonality among N . gonorrhoeae clinical isolates with decreased susceptibilities to fluoroquinolones. In conclusion, this study suggests that the emergence of quinolone-resistant strains in some parts of the world, including Japan, is due to invivo multiclonal selection of strains with genetic alterations in D NA gyrase and topoisomerase IV, in addition to the spread of quinolone-resistant clones.
